Cargando…
Statins use and COVID-19 outcomes in hospitalized patients
BACKGROUND: There is an urgent need for novel therapeutic strategies for reversing COVID-19-related lung inflammation. Recent evidence has demonstrated that the cholesterol-lowering agents, statins, are associated with reduced mortality in patients with various respiratory infections. We sought to i...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432819/ https://www.ncbi.nlm.nih.gov/pubmed/34506533 http://dx.doi.org/10.1371/journal.pone.0256899 |
_version_ | 1783751245321732096 |
---|---|
author | Ayeh, Samuel K. Abbey, Enoch J. Khalifa, Banda A. A. Nudotor, Richard D. Osei, Albert Danso Chidambaram, Vignesh Osuji, Ngozi Khan, Samiha Salia, Emmanuella L. Oduwole, Modupe O. Yusuf, Hasiya E. Lasisi, Oluwatobi Nosakhare, Esosa Karakousis, Petros C. |
author_facet | Ayeh, Samuel K. Abbey, Enoch J. Khalifa, Banda A. A. Nudotor, Richard D. Osei, Albert Danso Chidambaram, Vignesh Osuji, Ngozi Khan, Samiha Salia, Emmanuella L. Oduwole, Modupe O. Yusuf, Hasiya E. Lasisi, Oluwatobi Nosakhare, Esosa Karakousis, Petros C. |
author_sort | Ayeh, Samuel K. |
collection | PubMed |
description | BACKGROUND: There is an urgent need for novel therapeutic strategies for reversing COVID-19-related lung inflammation. Recent evidence has demonstrated that the cholesterol-lowering agents, statins, are associated with reduced mortality in patients with various respiratory infections. We sought to investigate the relationship between statin use and COVID-19 disease severity in hospitalized patients. METHODS: A retrospective analysis of COVID-19 patients admitted to the Johns Hopkins Medical Institutions between March 1, 2020 and June 30, 2020 was performed. The outcomes of interest were mortality and severe COVID-19 infection, as defined by prolonged hospital stay (≥ 7 days) and/ or invasive mechanical ventilation. Logistic regression, Cox proportional hazards regression and propensity score matching were used to obtain both univariable and multivariable associations between covariates and outcomes in addition to the average treatment effect of statin use. RESULTS: Of the 4,447 patients who met our inclusion criteria, 594 (13.4%) patients were exposed to statins on admission, of which 340 (57.2%) were male. The mean age was higher in statin users compared to non-users [64.9 ± 13.4 vs. 45.5 ± 16.6 years, p <0.001]. The average treatment effect of statin use on COVID-19-related mortality was RR = 1.00 (95% CI: 0.99–1.01, p = 0.928), while its effect on severe COVID-19 infection was RR = 1.18 (95% CI: 1.11–1.27, p <0.001). CONCLUSION: Statin use was not associated with altered mortality, but with an 18% increased risk of severe COVID-19 infection. |
format | Online Article Text |
id | pubmed-8432819 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-84328192021-09-11 Statins use and COVID-19 outcomes in hospitalized patients Ayeh, Samuel K. Abbey, Enoch J. Khalifa, Banda A. A. Nudotor, Richard D. Osei, Albert Danso Chidambaram, Vignesh Osuji, Ngozi Khan, Samiha Salia, Emmanuella L. Oduwole, Modupe O. Yusuf, Hasiya E. Lasisi, Oluwatobi Nosakhare, Esosa Karakousis, Petros C. PLoS One Research Article BACKGROUND: There is an urgent need for novel therapeutic strategies for reversing COVID-19-related lung inflammation. Recent evidence has demonstrated that the cholesterol-lowering agents, statins, are associated with reduced mortality in patients with various respiratory infections. We sought to investigate the relationship between statin use and COVID-19 disease severity in hospitalized patients. METHODS: A retrospective analysis of COVID-19 patients admitted to the Johns Hopkins Medical Institutions between March 1, 2020 and June 30, 2020 was performed. The outcomes of interest were mortality and severe COVID-19 infection, as defined by prolonged hospital stay (≥ 7 days) and/ or invasive mechanical ventilation. Logistic regression, Cox proportional hazards regression and propensity score matching were used to obtain both univariable and multivariable associations between covariates and outcomes in addition to the average treatment effect of statin use. RESULTS: Of the 4,447 patients who met our inclusion criteria, 594 (13.4%) patients were exposed to statins on admission, of which 340 (57.2%) were male. The mean age was higher in statin users compared to non-users [64.9 ± 13.4 vs. 45.5 ± 16.6 years, p <0.001]. The average treatment effect of statin use on COVID-19-related mortality was RR = 1.00 (95% CI: 0.99–1.01, p = 0.928), while its effect on severe COVID-19 infection was RR = 1.18 (95% CI: 1.11–1.27, p <0.001). CONCLUSION: Statin use was not associated with altered mortality, but with an 18% increased risk of severe COVID-19 infection. Public Library of Science 2021-09-10 /pmc/articles/PMC8432819/ /pubmed/34506533 http://dx.doi.org/10.1371/journal.pone.0256899 Text en © 2021 Ayeh et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Ayeh, Samuel K. Abbey, Enoch J. Khalifa, Banda A. A. Nudotor, Richard D. Osei, Albert Danso Chidambaram, Vignesh Osuji, Ngozi Khan, Samiha Salia, Emmanuella L. Oduwole, Modupe O. Yusuf, Hasiya E. Lasisi, Oluwatobi Nosakhare, Esosa Karakousis, Petros C. Statins use and COVID-19 outcomes in hospitalized patients |
title | Statins use and COVID-19 outcomes in hospitalized patients |
title_full | Statins use and COVID-19 outcomes in hospitalized patients |
title_fullStr | Statins use and COVID-19 outcomes in hospitalized patients |
title_full_unstemmed | Statins use and COVID-19 outcomes in hospitalized patients |
title_short | Statins use and COVID-19 outcomes in hospitalized patients |
title_sort | statins use and covid-19 outcomes in hospitalized patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432819/ https://www.ncbi.nlm.nih.gov/pubmed/34506533 http://dx.doi.org/10.1371/journal.pone.0256899 |
work_keys_str_mv | AT ayehsamuelk statinsuseandcovid19outcomesinhospitalizedpatients AT abbeyenochj statinsuseandcovid19outcomesinhospitalizedpatients AT khalifabandaaa statinsuseandcovid19outcomesinhospitalizedpatients AT nudotorrichardd statinsuseandcovid19outcomesinhospitalizedpatients AT oseialbertdanso statinsuseandcovid19outcomesinhospitalizedpatients AT chidambaramvignesh statinsuseandcovid19outcomesinhospitalizedpatients AT osujingozi statinsuseandcovid19outcomesinhospitalizedpatients AT khansamiha statinsuseandcovid19outcomesinhospitalizedpatients AT saliaemmanuellal statinsuseandcovid19outcomesinhospitalizedpatients AT oduwolemodupeo statinsuseandcovid19outcomesinhospitalizedpatients AT yusufhasiyae statinsuseandcovid19outcomesinhospitalizedpatients AT lasisioluwatobi statinsuseandcovid19outcomesinhospitalizedpatients AT nosakhareesosa statinsuseandcovid19outcomesinhospitalizedpatients AT karakousispetrosc statinsuseandcovid19outcomesinhospitalizedpatients |